Small explorers led the ASX week, with Lachlan Star, EcoGraf and Basin Energy recording the biggest gains on new drilling, offtake and exploration news.
Takeovers, capital raisings and strong company results also drew attention, although several large stocks fell despite reporting better earnings.
- Lachlan Star (ASX:LSA) jumped 55.00% after reporting shallow, high-grade gold at New Waverley.
- EcoGraf (ASX:EGR) rose 39.53% after doubling planned German graphite sales to 40,000 tonnes a year.
- Basin Energy (ASX:BSN) gained 36.36% as follow-up drilling began along a 3.3-kilometre rare earths zone.
- BetMakers (ASX:BET) agreed to a $283 million takeover, while Cleanaway (ASX:CWY) received a $3.13 per share offer.
- Telstra (ASX:TLS), Commonwealth Bank (ASX:CBA) and SGH (ASX:SGH) fell despite reporting earnings growth and shareholder returns.
Gold explorer Lachlan Star, graphite developer EcoGraf and rare earths explorer Basin Energy were the week’s biggest movers. Lachlan Star (ASX:LSA) surged 55.00% after drilling found several shallow, high-grade gold intersections at New Waverley. EcoGraf (ASX:EGR) climbed 39.53% after securing a deal that could double German graphite sales to 40,000 tonnes a year. Basin Energy (ASX:BSN) added 36.36% as it started more drilling across a 3.3-kilometre rare earths corridor.
Explorers set the pace
Buying stayed strongest in small mining stocks with new field results. Lachlan Star’s rise continued after its reopening, with the shares now 44.19% above the reopening price of 10.8 cents. That shows buyers stayed active after the first jump. The company still needs more assays to show the size and consistency of the gold system.
EcoGraf gained because the German agreement gives its Epanko project a larger potential customer base. The contract includes a pricing floor, which can protect part of the sales price if graphite prices fall. Investors will still want to see project financing, construction and actual deliveries before treating the sales plan as income.
Basin Energy’s drilling news gave investors a clear next step. The company is testing whether rare earth mineralisation continues along the corridor. Assays are due from mid to late September. Until then, the market has evidence of mineralisation but not a completed resource estimate or mine plan.
Deals and new capital reshape the field
Takeover activity also moved several shares. BetMakers (ASX:BET) rose 33.33% after Tabcorp agreed to pay about $283 million, or 24 cents a share. The offer includes a choice between cash and some Tabcorp shares. The shares have since slipped 4.35% from their reopening price, so early gains have partly evaporated while investors wait for approvals.
Cleanaway (ASX:CWY) gained 13.87% after EQT Infrastructure proposed $3.13 a share. The board plans to recommend the offer if a binding deal is signed and no better bid appears. FleetPartners (ASX:FPR) rose 21.33% after rejecting a lower bid and considering a possible $3.80 to $4.00 offer from Element Fleet Management. No final deal exists yet.
Capital raisings funded several development plans. Wia Gold (ASX:WIA) secured A$125 million for the Kokoseb project, while Challenger Gold (ASX:CEL) raised A$85 million for Hualilán. Starpharma (ASX:SPL) raised $32 million for an early-stage cancer drug trial. These deals provide cash for work ahead, but they also increase the number of shares in issue.
Results brought mixed share-price responses
Large companies reported solid numbers, but investors often sold the shares. Commonwealth Bank (ASX:CBA) reported a 7% rise in statutory profit and lifted its total dividend to 505 cents. Its shares fell 6.09%. Telstra (ASX:TLS) also fell 4.02% despite higher earnings, a 14% rise in cash earnings per share and a new $1 billion buy-back. The July network outage remains under investigation, which may have worried shareholders.
SGH (ASX:SGH) dropped 9.96% after reporting a small rise in earnings and a $500 million buy-back. Life360 (ASX:360) fell 17.58% even though users passed 102 million and adjusted earnings rose 53%. The shares are 20.50% below their reopening price, an air pocket that suggests sellers overwhelmed the positive operating figures.
Elsewhere, Chrysos (ASX:C79) rose 18.20% after revenue reached $88.1 million and its PhotonAssay fleet expanded to 46 units. IPD Group (ASX:IPG) gained 17.28% after beating its earnings guidance. Computershare (ASX:CPU) fell 5.73% despite raising its final dividend by 35%, showing that a good result does not always bring immediate buying.
Healthcare and technology wait for proof
Healthcare and technology stocks produced several important announcements. Pro Medicus (ASX:PME) secured a seven-year, A$23 million cloud imaging contract with St Luke’s Health System in the United States. ReNerve (ASX:RNV) received Indian approval for its nerve repair product. Alterity Therapeutics (ASX:ATH) extended United States patent protection for its lead drug to at least 2045.
These announcements improve access to customers or protect future products. They do not guarantee large sales. Investors will watch Pro Medicus for the contract rollout, ReNerve for commercial orders and Alterity for progress towards its next clinical trial.
Bottom Line?
The next stage of the week’s stories will depend on evidence still to come. September assays will test Basin Energy’s rare earths corridor, while Lachlan Star awaits more gold results. BetMakers, Cleanaway and FleetPartners must move through deal approvals or negotiations. Wia Gold and Challenger Gold now need to turn new funding into project work. Company investors will also watch whether buy-backs, dividends and earnings growth can overcome concerns about outages, impairments and higher spending.
Questions in the middle?
- Will Lachlan Star’s follow-up drilling show that the high-grade gold extends far enough to support a resource estimate?
- Can Basin Energy confirm continuous rare earths grades when its September assays arrive?
- Will the proposed takeovers of BetMakers, Cleanaway and FleetPartners become binding deals, or will terms change?